DR. MANISH SHARMA M.D. NPI 1790819332

NPI Information

  • NPI: 1790819332
  • Provider Name: DR. MANISH SHARMA, M.D.
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 5800 FOREMOST DR SE STE 100
    GRAND RAPIDS, MI
    ZIP 49546
  • Phone: (616) 954-5554

Map and Directions

Get Directions

NPI Details

DR. Manish Sharma, M.D. is a medical oncology internal medicine in Grand Rapids, MI with 22 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Manish Sharma, M.D. NPI is 1790819332. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MICHIGAN MEDICAL SCHOOL
Graduation Year:2004

The provider's business location address is:

5800 FOREMOST DR SE STE 100
GRAND RAPIDS, MI
ZIP 49546
Phone: (616) 954-5554
Fax: (616) 451-9120

The NPI 1790819332 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, fulvestrant, 25 mg (HCPCS:J9395)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Magnesium level (HCPCS:83735)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Unclassified drugs (HCPCS:J3490)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Blood test, clotting time (HCPCS:85610)
  • Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Hospital discharge day management, more than 30 minutes (HCPCS:99239)

The enumeration date for this NPI number is 3/15/2007 and was last updated on 3/17/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical Oncology4301116174MICHIGANYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.